David O. Watson
CIK 1657719 · General Counsel · last filed 2026-05-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
1
Total Filings
59
Lifetime Open-Market Net
-$6.80M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Apellis Pharmaceuticals, Inc. (APLS) Delisted | General Counsel | 0 | $41.03 | $0 | -$6.80M | 59 | 2026-05-14 |
Recent Filings · Page 2 of 6
59 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-09-12 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −20,000 | -$523.4K | EDGAR |
| 2025-08-19 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −5,000 | -$139.0K | EDGAR |
| 2025-07-18 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −5,000 | -$97.8K | EDGAR |
| 2025-06-18 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −5,000 | -$93.8K | EDGAR |
| 2025-06-11 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-03-06 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Mixed | −5,569 | -$139.8K | EDGAR |
| 2025-01-30 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −695 | -$20.5K | EDGAR |
| 2025-01-23 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −3,323 | -$101.1K | EDGAR |
| 2025-01-21 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Mixed | +40,561 | -$65.9K | EDGAR |
| 2025-01-14 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −4,965 | -$142.5K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.